AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 2958282
Drug: Sodium cromoglycate
RxNorm normalized name: Sodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium cromoglycate (20 mg/2 ml)
Trial: 2958282
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide (500 micrograms/2 ml)
Trial: 2958282
Drug: Verapamil (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (5 mg/2 ml)
Trial: 2958282
Drug: Verapamil (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (10 mg in 4 ml) after placebo (4 ml saline)
Trial: 2665559
Drug: 0.32 g
RxNorm normalized name: ZINC OXIDE 0.32 g in 4 g TOPICAL STICK [eos Natural SPF 15 Lip Balm Pineapple Coconut]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.32 g alcohol/kg body weight
Trial: 2665559
Drug: 0.65 g
RxNorm normalized name: Tumil-K 2 MEQ/0.65 GM Oral Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.65 g alcohol/kg body weight
Trial: 2665559
Drug: 0.81 g
RxNorm normalized name: TITANIUM DIOXIDE 0.81 g in 45 g CUTANEOUS CREAM [THE SKIN EXTRA BB SPF20 PA]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.81 g alcohol/kg body weight
Trial: 779949
Drug: 5-FU 400
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-FU 400 mg/m2 weekly intravenously
Trial: 779949
Drug: 5-FU 400
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-FU 400 mg/m2 i.v. weekly plus methyl-CCNU 175 mg/m2 orally every 6 weeks
Trial: 30402705
Drug: Reduced bowel
RxNorm normalized name: ascorbic acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reduced bowel preparation (r‐CTC)
Trial: 30402705
Drug: Full bowel
RxNorm normalized name: ascorbic acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Full bowel preparation (f‐CTC)
Trial: 29141858
Drug: Anakinra 100
RxNorm normalized name: ANAKINRA 100MG INJ,SYRINGE,1ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anakinra 100 mg daily subcutaneous injections for 12 weeks
Trial: 29141858
Drug: Anakinra 100
RxNorm normalized name: ANAKINRA 100MG INJ,SYRINGE,1ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anakinra 100 mg daily subcutaneous injections for 2 weeks
Trial: 23940237
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (iNO) 5 ppm for 7 to 21 days
Trial: 18041047
Drug: Drug therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug therapies for schizophrenic patients
Trial: 29137502
Drug: Chlorhexidine solution
RxNorm normalized name: CHLORHEXIDINE GLUCONATE 99.0 g in 1 L TOPICAL SOLUTION [CHLORHEXIDINE Solution]
DrugBank: Chlorhexidine (DB00878)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorhexidine solution applied to umbilical cord stumps
Trial: 24270900
Drug: parecoxib sodium
RxNorm normalized name: parecoxib sodium
DrugBank: Parecoxib (DB08439)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: parecoxib sodium 40 mg (Group P, n=40)
Trial: 24270900
Drug: tramadol 2
RxNorm normalized name: traMADol 25 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tramadol 2 mg/kg (Group T, n=40)
Trial: 12572527
Drug: Fusafungine nasal
RxNorm normalized name: fusafungin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fusafungine nasal spray
Trial: 9459381
Drug: 3.5 g
RxNorm normalized name: Calcium 760 MG/3.5 GM Oral Granule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.5 g psyllium three times daily
Trial: 11114960
Drug: Simvastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (20 mg day-1)
Trial: 12534449
Drug: Pravastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin (40 mg day-1)
Trial: 27136960
Drug: Split-dose polyethylene
RxNorm normalized name: polyethylenes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Split-dose polyethylene glycol (PEG)
Trial: 26281972
Drug: GLAR +
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: GLAR + metformin
Trial: 26281972
Drug: 3OAD (metformin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3OAD (metformin or glyburide)
Trial: 18612703
Drug: Postoperative combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative combined modality adjuvant therapy (chemotherapy, chemoradiation, or both); specific dosages and durations not mentioned.
Trial: 18612703
Drug: Adjuvant therapy;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant therapy; specific type not mentioned.
Trial: 15773068
Drug: Standard pharmaceutical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard pharmaceutical grade placebo
Trial: 10086330
Drug: Daily doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily doses of 9 or 12 x 10(6) IL‐2 units/m2
Trial: 10086330
Drug: Daily doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily doses of 3 or 6 10(6) IL‐2 units/m2
Trial: 7139063
Drug: Sustained release
RxNorm normalized name: Sustained Release Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained release formulation
Trial: 7139063
Drug: Three 25
RxNorm normalized name: THREE-LOBE SAGE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three 25 mg conventional doses given at 4‐h intervals (control)
Trial: 7139063
Drug: Single 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single 75 mg dose of conventional capsules (control)
Trial: 7139063
Drug: Intravenous dose
RxNorm normalized name: Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous dose (control)
Trial: 31952174
Drug: CrM-HMB (0.04
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CrM-HMB (0.04 g/kg/day of CrM plus 3 g/day of HMB)
Trial: 20084326
Drug: Transdermal nitroglycerin
RxNorm normalized name: nitroglycerin Transdermal System
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal nitroglycerin (10 mg patch)
Trial: 17027104
Drug: NO-releasing aspirin
RxNorm normalized name: aspirin Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NO-releasing aspirin (NORA)
Trial: 15478208
Drug: Essential oil
RxNorm normalized name: Essential oil
DrugBank: Rosemary oil (DB14689)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Essential oil spray or gargle formulation
Trial: 11682284
Drug: Chronobiological interventions
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronobiological interventions related to reproductive hormones (specific details not provided)
Trial: 10211010
Drug: Midazolam 0.2
RxNorm normalized name: midazolam 0.2 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.2 mg kg‐1 as drops
Trial: 10211010
Drug: Midazolam 0.1
RxNorm normalized name: midazolam 0.1 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.1 mg kg‐1 from an intranasal spray device
Trial: 10211010
Drug: Intranasal midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intranasal midazolam (both methods)
Trial: 8165823
Drug: Fenoterol (F)
RxNorm normalized name: fenoterol
DrugBank: Fenoterol (DB01288)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoterol (F) administered intravenously (i.v.)
Trial: 8165823
Drug: Fenoterol (F)
RxNorm normalized name: fenoterol
DrugBank: Fenoterol (DB01288)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoterol (F) administered orally (p.o.)
Trial: 2893084
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of serum CA‐125 measurement with ultrasound
Trial: 2893084
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of vaginal examination with ultrasound
Trial: 2893084
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of serum CA‐125 measurement with vaginal examination
Trial: 2893084
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of all three tests (serum CA‐125 measurement, vaginal examination, ultrasound)
Trial: 29501386
Drug: Antipsychotic medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipsychotic medication (olanzapine, clozapine, quetiapine)
Trial: 28463833
Drug: 10 mg/h
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/h clazosentan
Trial: 21477171
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of caesarean and spontaneous vaginal births
Trial: 12433231
Drug: Modafinil (three
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modafinil (three 100 mg doses per day)
Trial: 1888693
Drug: Diltiazem 300
RxNorm normalized name: diltiazem 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem 300 mg once daily for 3 weeks
Trial: 22151478
Drug: Abstinence-contingent recovery
RxNorm normalized name: Chem-Star Recover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abstinence-contingent recovery housing with reinforcement-based treatment (RH + RBT)
Trial: 16389162
Drug: Basal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Basal insulin + Pio (30 mg daily)
Trial: 16389162
Drug: Sulfonylurea and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfonylurea and Metformin (SU+M)
Trial: 11077389
Drug: Penicillin (28
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Penicillin (28 capsules, 500 mg each, taken every 6 hours for 7 days)
Trial: 8724325
Drug: Adjunctive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive treatment with lithium or carbamazepine
Trial: 8724325
Drug: High doses
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High doses of neuroleptics
Trial: 31013372
Drug: Oral Immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Immunotherapy (OIT) for peanut allergy over 2 years
Trial: 30524424
Drug: Oral Immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Immunotherapy (OIT) for peanut allergy
Trial: 30209017
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (ambrisentan 10 mg plus tadalafil 40 mg)
Trial: 30209017
Drug: Monotherapy (either
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy (either ambrisentan or tadalafil plus placebo)
Trial: 22525081
Drug: Ketorolac tromethamine
RxNorm normalized name: Ketorolac Tromethamine
DrugBank: Ketorolac (DB00465)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketorolac tromethamine formulation (31.5 mg) administered intranasally
Trial: 22525081
Drug: Nasal inhalation
RxNorm normalized name: Nasal Inhalant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal inhalation (gentle or vigorous sniff)
Trial: 22525081
Drug: Nasal spray
RxNorm normalized name: Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal spray pump delivery device
Trial: 22525081
Drug: Gentle inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentle inhalation
Trial: 16000624
Drug: Propranolol (beta‐adrenoceptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (beta‐adrenoceptor antagonist)
Trial: 16000624
Drug: Reboxetine (selective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reboxetine (selective norepinephrine reuptake inhibitor)
Trial: 11916759
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A (1500 retinol equivalents or 5000 IU) and Zinc (15 mg) supplementation daily for 6 months
Trial: 7564449
Drug: Warm antegrade
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warm antegrade delivery of cardioplegic solution (N = 25)
Trial: 7564449
Drug: Warm retrograde
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warm retrograde delivery of cardioplegic solution (N = 25)
Trial: 7564449
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of warm antegrade and retrograde delivery of cardioplegic solution (N = 25)
Trial: 7023308
Drug: Digoxin treatment
RxNorm normalized name: Digoxin
DrugBank: Digoxin (DB00390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Digoxin treatment for 8 weeks
Trial: 30613990
Drug: Herpes zoster
RxNorm normalized name: ZOSTER VACCINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herpes zoster vaccine (4.3 log plaque-forming unit)
Trial: 30613990
Drug: Herpes zoster
RxNorm normalized name: ZOSTER VACCINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herpes zoster vaccine (4.7 log plaque-forming unit)
Trial: 30613990
Drug: Herpes zoster
RxNorm normalized name: ZOSTER VACCINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herpes zoster vaccine (4.9 log plaque-forming unit)
Trial: 25407688
Drug: Zen meditation
RxNorm normalized name: benzalkonium chloride Topical Foam [Meditize]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zen meditation (MG) - meditated twice a day for 20 minutes for 3 months
Trial: 25407688
Drug: Zen meditation
RxNorm normalized name: benzalkonium chloride Topical Foam [Meditize]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zen meditation (MG)
Trial: 19692317
Drug: Intravesical BCG
RxNorm normalized name: BCG, live, Tice strain
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical BCG treatment (81 mg for 6 weeks)
Trial: 8223740
Drug: Prazosin (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prazosin (0.25 mg and 0.50 mg)
Trial: 29713909
Drug: Rifaximin (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifaximin (600 mg/day)
Trial: 27435761
Drug: Capecitabine 1500
RxNorm normalized name: Capecitabine
DrugBank: Capecitabine (DB01101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Capecitabine 1500 mg/daily continuously with rabeprazole 1.5 mg/kg twice a day, 3 days a week
Trial: 27435761
Drug: Capecitabine 1500
RxNorm normalized name: Capecitabine
DrugBank: Capecitabine (DB01101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Capecitabine 1500 mg/daily continuously without rabeprazole
Trial: 20118792
Drug: Landiolol (continuous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Landiolol (continuous administration during anesthesia)
Trial: 15676092
Drug: Mild hypothermia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mild hypothermia therapy (n=20)
Trial: 15676092
Drug: Normothermia therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normothermia therapy (n=20)
Trial: 11846857
Drug: Levofloxacin 500
RxNorm normalized name: levofloxacin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levofloxacin 500 mg twice/day for 6 days along with 0.4 mg digoxin on study day 5
Trial: 28340244
Drug: Bupropion (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupropion (150 mg/d for 7 days)
Trial: 25469804
Drug: Candesartan (target
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan (target dose 16 mg/d)
Trial: 23884659
Drug: CJ leflunomide
RxNorm normalized name: Leflunomide
DrugBank: Leflunomide (DB01097)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CJ leflunomide 10 mg
Trial: 23884659
Drug: CJ leflunomide
RxNorm normalized name: Leflunomide
DrugBank: Leflunomide (DB01097)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CJ leflunomide 20 mg
Trial: 23884659
Drug: Arava® (reference
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arava® (reference drug)
Trial: 16870004
Drug: Hot skimmed
RxNorm normalized name: Red Hot
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hot skimmed milk formulation (15 mg zeaxanthin)
Trial: 16870004
Drug: Warm skimmed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warm skimmed milk formulation (15 mg zeaxanthin)
Trial: 16870004
Drug: Hot water
RxNorm normalized name: hot water bottle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hot water formulation (15 mg zeaxanthin)
Trial: 10851837
Drug: One dose
RxNorm normalized name: Next Choice One Dose
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: One dose of vitamin A
Trial: 9166880
Drug: Swallowing therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Swallowing therapy with videoendoscopic biofeedback
Trial: 21336727
Drug: Conventional swallowing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional swallowing therapy
Trial: 25978852
Drug: 400 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 μg Folic Acid
Trial: 25978852
Drug: 800 μg
RxNorm normalized name: hyaluronidase
DrugBank: Hyaluronidase (DB14740)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 800 μg Folic Acid
Trial: 25978852
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g Creatine
Trial: 25978852
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g Creatine + 400 μg Folic Acid
Trial: 20433248
Drug: 3% prilocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3% prilocaine with 0.03IU/mL felypressin
Trial: 16750464
Drug: Nepafenac ophthalmic
RxNorm normalized name: nepafenac ophthalmic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nepafenac ophthalmic suspension 0.03%
Trial: 17621177
Drug: Diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac sodium ophthalmic solution 0.1%
Trial: 15142073
Drug: Vaseline applied
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaseline applied twice a day bilaterally for 4 weeks
Trial: 11312048
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg morphine into inflamed submucous tissue
Trial: 11312048
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg morphine into non-inflamed tissue
Trial: 11312048
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg morphine perineurally
Trial: 9202804
Drug: Aerosolized furosemide
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aerosolized furosemide (2 mg/kg)
Trial: 8187026
Drug: Inhaled phosphoramidon
RxNorm normalized name: phosphoramidic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled phosphoramidon (10(-5) M)
Trial: 8187026
Drug: Inhaled NKA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled NKA
Trial: 25343850
Drug: Whey protein/fibre
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whey protein/fibre preload (17 g whey protein, 3 g lactose, 5 g guar, 1 g flavour material in 150 ml cold water)
Trial: 25343850
Drug: Control (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (150 ml cold water with no additives)
Trial: 23755872
Drug: 6 hours
RxNorm normalized name: nitroglycerin 0.6 MG/HR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 hours of daily patching
Trial: 23755872
Drug: 2 hours
RxNorm normalized name: PATCH, TRANSDERMAL 72 HOURS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 hours of daily patching
Trial: 1503519
Drug: recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: recombinant human growth hormone (hGH; 0.3 U/kg/24 hours)
Trial: 6510453
Drug: Sustained-release metoprolol
RxNorm normalized name: metoprolol Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release metoprolol (200 mg)
Trial: 25781198
Drug: Arginine-based supplement
RxNorm normalized name: Arginine
DrugBank: Arginine (DB00125)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Arginine-based supplement (3.0 g of arginine, 300 mg of grape seed extract, and 300 mg of polyethylene glycol)
Trial: 25781198
Drug: Arginine-based supplement
RxNorm normalized name: Arginine
DrugBank: Arginine (DB00125)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Arginine-based supplement
Trial: 19542795
Drug: IVPCA morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVPCA morphine plus ketorolac (M+K group)
Trial: 19542795
Drug: IVPCA morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVPCA morphine (M group)
Trial: 9049514
Drug: Ramipril 5
RxNorm normalized name: ramipril 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril 5 mg b.d.
Trial: 3524550
Drug: Intracervical PGF2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracervical PGF2 alpha gel
Trial: 8814744
Drug: Topical ganciclovir
RxNorm normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical ganciclovir 0.15% gel
Trial: 26671622
Drug: Topical 0.4%
RxNorm normalized name: fluoride topical 0.4% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 0.4% povidone-iodine solution
Trial: 26671622
Drug: Preservative-free artificial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preservative-free artificial tears and topical antibiotics